History
  • No items yet
midpage
Pfizer Inc. v. McNeil-PPC, Inc.
708 F. App'x 14
| 2d Cir. | 2017
Read the full case

Background

  • Pfizer appealed a district court grant of judgment on the pleadings for McNeil-PPC, challenging the scope of a 1989 consent Judgment entered in prior litigation between the parties.
  • The 1989 Judgment barred Pfizer’s predecessor from advertising that "ADVIL is 'like TYLENOL' in the respect of adverse effects on the stomach."
  • Central dispute: whether the term "ADVIL" in the Judgment refers only to the adult Advil product at issue in the 1980s litigation or to all Advil products containing ibuprofen (including pediatric/infant formulations approved later).
  • The Judgment incorporates by reference Judge Conner’s 1987 opinion in McNeilab, Inc. v. American Home Products Corp., which the parties dispute whether it resolves the scope question.
  • The Second Circuit reviewed de novo whether the Judgment is ambiguous and whether extrinsic evidence may be considered to determine the parties’ intent.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the term "ADVIL" in the 1989 Judgment unambiguously covers only the adult Advil product at issue in the 1980s litigation "ADVIL" should be read narrowly to mean the specific adult product litigated in the 1980s "ADVIL" should be read broadly to cover all ibuprofen-containing Advil products, including pediatric formulations The Judgment is ambiguous on this point; not resolved by the incorporated 1987 opinion, so extrinsic evidence is admissible to determine intent
Whether the district court properly resolved the scope issue on a Rule 12(c) motion without permitting extrinsic evidence The ambiguity can be resolved against McNeil on the pleadings The language and incorporated opinion foreclose Pfizer’s broader reading so judgment for McNeil was proper Court vacated district court decision and remanded for further proceedings allowing extrinsic evidence

Key Cases Cited

  • Kirkendall v. Halliburton, 707 F.3d 173 (2d Cir.) (standard of review for Rule 12(c): de novo)
  • Pandora Media, Inc. v. Am. Soc’y of Composers, Authors & Publishers, 785 F.3d 73 (2d Cir.) (consent decree interpretation reviewed de novo)
  • Doe v. Pataki, 481 F.3d 69 (2d Cir.) (consent decrees treated like contracts for interpretation)
  • U.S. ex rel. Anti-Discrimination Ctr. of Metro N.Y., Inc. v. Westchester Cty., 712 F.3d 761 (2d Cir.) (contract interpretation principles apply to consent decrees)
  • In re World Trade Ctr. Disaster Site Litig., 754 F.3d 114 (2d Cir.) (clear and unambiguous written agreements enforced by plain meaning)
  • JA Apparel Corp. v. Abboud, 568 F.3d 390 (2d Cir.) (extrinsic evidence permitted where contract language is ambiguous)
  • McNeilab, Inc. v. American Home Products Corp., 675 F. Supp. 819 (S.D.N.Y.) (opinion incorporated into the 1989 Judgment; court found it does not resolve the ambiguity)
Read the full case

Case Details

Case Name: Pfizer Inc. v. McNeil-PPC, Inc.
Court Name: Court of Appeals for the Second Circuit
Date Published: Sep 15, 2017
Citation: 708 F. App'x 14
Docket Number: 16-1743
Court Abbreviation: 2d Cir.